emoxypine succinate has been researched along with Cerebrovascular Disorders in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Kuznetsov, NS; Kuznetsova, EB; Salina, EA | 1 |
Kunelskaya, NL; Larionova, EV; Levina, YV; Ogorodnikov, DS; Yanyushkina, ES | 1 |
Gudasheva, TA; Povarnina, PY; Seredenin, SB; Volkova, AA | 1 |
Gorbunov, FE; Penionzhkevich, DIu | 1 |
Antonova, KV; Lagoda, OV; Tanashian, MM | 1 |
5 other study(ies) available for emoxypine succinate and Cerebrovascular Disorders
Article | Year |
---|---|
[Efficacy of Mexidol in the correction of postcovid syndrome in patients with chronic cerebrovascular diseases].
Topics: Antioxidants; Asthenia; Cerebrovascular Disorders; Chronic Disease; COVID-19; Humans; Syndrome | 2023 |
[Possibility of application Mexidol for the treatment of patients suffering from sensorineural hearing loss and cerebrovascular insufficiency].
Topics: Antioxidants; Auditory Threshold; Cerebrovascular Disorders; Hearing Loss, Sensorineural; Humans; Picolines; Speech Intelligibility | 2019 |
Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats.
Topics: Animals; Brain Ischemia; Cerebrovascular Disorders; Dipeptides; Disease Models, Animal; Drug Administration Schedule; Injections, Intraperitoneal; Middle Cerebral Artery; Molecular Mimicry; Neuroprotective Agents; Neurotrophin 3; Picolines; Rats; Rats, Wistar; Stroke | 2017 |
[New technologies of neurometabolic therapy of cerebrovascular diseases].
Topics: Adult; Aged; Antioxidants; Cerebrovascular Circulation; Cerebrovascular Disorders; Electrophoresis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Organophosphorus Compounds; Picolines; Transcranial Magnetic Stimulation; Treatment Outcome | 2009 |
[Chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches].
Topics: Aged; Antioxidants; Cerebrovascular Disorders; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Picolines; Treatment Outcome | 2012 |